New insights into acquired resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor therapy in lung cancer
Fassunke, J., Heydt, C., Michels, S., Van Veggel, B., Müller, F., Keul, M., Dammert, M.A., Schmitt, A., Smit, E.F., Kast, S., Wolf, J., Buettner, R., Sos, M.L., Rauh, D., Merkelbach-Bruse, S.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article